A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Recent news on Didanosine


Five Days Of LEVAQUIN(R) As Effective As 10 Days Of Ciprofloxacin ...  -  May 22, 2007
Medical News Today (press release),...metal cations such as iron, and multivitamin preparations with zinc, or Videx(R) (didanosine) chewable/buffered tablets or the pediatric powder for oral

Five Days of LEVAQUIN(R) as Effective as 10 Days of Ciprofloxacin ...  -  May 21, 2007
PR Newswire (press release),...and multivitamin preparations with zinc, or Videx(R)* (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, should be taken

5 Days Of Levaquin As Effective As 10 Days Of Ciprofloxacin In ...  -  May 21, 2007
eMaxHealth.com,Antacids containing magnesium or aluminum, as well as sucralfate, metal cations such as iron, and multivitamin preparations with zinc, or Videx (didanosine)

Clinton Foundation announces new price cuts for tenofovir and ...  -  May 9, 2007
Aidsmap,...while another second-line nucleoside analogue, didanosine, falls from an average of $1096 in lower middle-income countries to $248 a year.

FDA Approves Oscient Pharmaceuticals' FACTIVE(R) Tablets for Five ...  -  May 2, 2007
PipelineReview.com (press release),...multivitamins containing metal cations, and didanosine. The safety and effectiveness of FACTIVE in children, adolescents (less than 18 years of age),

China and HIV — A Window of Opportunity  -  May 2, 2007
New England Journal of Medicine (subscription),Relying almost entirely on generic drugs produced in China, the country's first-line therapy regimens — zidovudine, didanosine, and nevirapine or zidovudine

Adverse effects of ARVs  -  Apr 1, 2007
ZimDaily,Didanosine. Nausea and vomiting are common. In above 6% of cases, pancreatitis (damage to pancreas, or rwatata in Shona); and damage to nerves of feet

d4T dose can be reduced without loss of effectiveness, meta ...  -  Apr 2, 2007
Aidsmap,A randomised, dose-finding study with didanosine plus stavudine versus didanosine alone in antiviral-naļve, HIV-infected Thai patients. AIDS 14:1375-1382,

Narrative Review: Antiretroviral Therapy to Prevent the Sexual ...  -  Apr 16, 2007
Annals of Internal Medicine3TC = lamivudine; ABC = abacavir; APV = amprenavir; ATV = atazanavir; d4T = stavudine; ddI = didanosine; DLV = delavirdine; EFV = efavirenz;

FDA Extends Marketing Exclusivity for LEVAQUIN(R  -  Mar 30, 2007
Drug Newswire (press release),...and multivitamin preparations with zinc, or Videx(R)* (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, should be taken

Merck & Co., Inc. To Distribute ATRIPLAâ„¢ in Developing Countries  -  Feb 16, 2007
WebWire (press release),Coadministration of ATRIPLA and didanosine should be undertaken with caution. Patients receiving this combination should be monitored closely for

'AIDS Drug Prices to Die For' - AIDS Healthcare Foundation Targets ...  -  Feb 23, 2007
PR Newswire (press release),...and Reyataz (atazanavir) and Videx (didanosine or DDL), both of which can be key components of effective combined AIDS drug regimens or cocktails.

New Treatment Guidelines for Community-Acquired Pneumonia ...  -  Feb 22, 2007
PharmaLive.com (press release),...interactions include probenicid, sucralfate, antacids containing aluminum or magnesium, iron, multivitamins containing metal cations, and didanosine.

HIV patients may have to pop pills just once a day  -  Jan 5, 2007
Pune Newsline,These include emtricitabine (FTC) and atazanavir plus didanosine enteric coated (ddI-EC) for the trial participants. “These tablets are being given just

Company Announces Acquisition of Research and Development Programs ...  -  Dec 26, 2006
Drug Newswire (press release),...registration of important drugs for the treatment of HIV and Cancer, including paclitaxel (Taxol(R)), didanosine (Videx(R)), and stavudine (Zerit(R)).

Company Announces Acquisition of Research and Development Programs ...  -  Dec 22, 2006
Yahoo! News (press release)...and registration of important drugs for the treatment of HIV and Cancer, including paclitaxel (Taxol®), didanosine (Videx®), and stavudine (Zerit®).

Antiretroviral Therapy for HIV: New Data From HIV 8 in Glasgow  -  Dec 26, 2006
Medscape (subscription)Therefore, weight-based ribavirin dosing should now be recommended in the HIV setting, and didanosine coadministration should always be avoided.

Antiretroviral Therapy for HIV: New Data From HIV 8 in Glasgow  -  26 Dec 2006
Medscape (subscription)Therefore, weight-based ribavirin dosing should now be recommended in the HIV setting, and didanosine coadministration should always be avoided.

South Africa: Scientists Warn State-Supplied Aids Drug Poses ...  -  Dec 6, 2006
AllAfrica.com,If patients develop severe side-effects or resistance, they switch to "second-line therapy", based on zidovudine (AZT), didanosine (ddI),

96-Week Data From Gilead’s Study 934 Comparing Viread ® and ...  -  Dec 15, 2006
Business Wire (press release),Coadministration of ATRIPLA and didanosine should be undertaken with caution. Patients receiving this combination should be monitored closely for

Company Announces Acquisition of Research and Development Programs ...  -  Dec 22, 2006
PR Newswire (press release),...registration of important drugs for the treatment of HIV and Cancer, including paclitaxel (Taxol(R)), didanosine (Videx(R)), and stavudine (Zerit(R)).

Company Announces Acquisition of Research and Development Programs ...  -  Dec 22, 2006
Yahoo! News (press release)...and registration of important drugs for the treatment of HIV and Cancer, including paclitaxel (Taxol®), didanosine (Videx®), and stavudine (Zerit®).

Triple nuke combination of AZT/3TC/tenofovir below current ...  -  Dec 17, 2006
Aidsmap,Despite reports emerging in 2003 that tenofovir/3TC in combination with abacavir (Ziagen) or ddI (didanosine, Videx/Videx EC) had a high rate of early

Breakthrough deal signed for paediatric HIV drugs  -  Dec 1, 2006
Pharma Times (subscription),The other ARVs for which the Clinton Foundation has negotiated price reductions include abacavir, didanosine, efavirenz and zidovudine.

President Clinton Announces Breakthroughs In HIV/AIDS Treatment ...  -  Nov 30, 2006
Medical News Today (press release),In addition to the three ARVs included in the pediatric FDC, the other ARVs for which CHAI has negotiated price reductions include abacavir, didanosine,

FDA Accepts as ``Complete Response'' Oscient Pharmaceuticals ...  -  Nov 28, 2006
PipelineReview.com (press release),...interactions include probenicid, sucralfate, antacids containing aluminum or magnesium, iron, multivitamins containing metal cations, and didanosine.

Aurobindo receives approval for Didanosine oral suspension  Oct 10, 2006
Aurobindo takes pleasure to inform that the US FDA has granted tentative approval for Aurobindo’s Didanosine Oral Suspension (Pediatric Powder) 10 mg / ml. ... -Moneycontrol.com, Aurobindo gets USFDA approval for Didanosine oral suspension  Oct 10, 2006
Aurobindo Pharma (Q, N,C,F)* has received the USFDA approval for the company`s Didanosine oral suspension (pediatric powder) 10 mg/ml. ... -Myiris.com, Second generic abacavir approved for PEPFAR  Nov 7, 2006
Abacavir is likely to be used in developing countries as a second-line nucleoside analogue in combination with didanosine or tenofovir and one drug from ... -Aidsmap, "Super Bug" Scares - Straight Facts About Antibiotic Resistance  Nov 6, 2006
...magnesium or aluminum, as well as sucralfate, metal cations such as iron, and multivitamin preparations with zinc, or Videx®* (didanosine) chewable/buffered ... -Medical News Today (press release), Aurobindo gets FDA nod for AIDS drug  Oct 11, 2006
Pharma Ltd has announced that the United Sates Food and Drug Administration (USFDA) has granted tentative approval for the company's Didanosine Oral Suspension ... -Moneycontrol.com, Bristol-Myers Squibb, Gilead Sciences And Merck & Co. Submit ...  Oct 10, 2006
Coadministration of ATRIPLA with didanosine should be undertaken with caution. Patients receiving this combination should be monitored ... -Medical News Today (press release), New risk factors for severe liver toxicity identified in largest ...  Nov 3, 2006
...dual therapy comprising a one of two nucleoside reverse transcriptase inhibitors (NRTIs) - including AZT (zidovudine, Retrovir), ddI (didanosine, Videx), ddC ... -Aidsmap, Aurobindo Gets FDA Nod for AIDS Drug  Oct 12, 2006
12, 2006--Aurobindo Pharma Ltd has announced that the US FDA has granted tentative approval for the company's Didanosine Oral Suspension (paediatric powder) 10 ... -Therapeutics Daily (subscription) (press release), Bristol-Myers Squibb, Gilead Sciences and Merck & Co. Submit ...  Oct 8, 2006
ATRIPLA should bediscontinued in patients who develop tenofovir-associated adverse events.Coadministration of ATRIPLA with didanosine should be undertaken ... -Earthtimes.org FACTIVE(R) Tablets Subject of Five Presentations at Third ...  Oct 9, 2006
Drug-drug interactions include probenicid, sucralfate, antacids containing aluminum or magnesium, iron, multivitamins containing metal cations, and didanosine. ... -Business Wire (press release), Findings from the United States, France and Canada in HIV/AIDS ...  Oct 12, 2006
..."The AIDS Clinical Trials Group (ACTG) study 384 randomized antiretroviral-naive individuals to receive didanosine/stavudine or zidovudine/lamivudine, plus ... -Therapeutics Daily (subscription) (press release), AIDS drug prices to fall by 32%  24 Sep 2006
Drugs such as Nevirapine, Lamivudine, Didanosine, Indinavir would come at prices that are 7% to 32% less than supplied by private companies. ... -Financial Express

AIDS drug prices to fall  24 Sep 2006
As per initial estimates, RDPL would be able to make a 30-tablet/capsule pack of Didanosine 400 mg at Rs 1173, cheaper by over Rs 200 than Cipla's price. ... -Times of India

Oscient Pharmaceuticals Receives Approvable Letter from FDA for ...  Sep 22, 2006
Drug-drug interactions include probenicid, sucralfate, antacids containing aluminum or magnesium, iron, multivitamins containing metal cations, and didanosine. ... -PharmaLive.com

Drug Combo Protects Arteries of HIV Patients  Sep 8, 2006
...used alone. The mice received a common protease inhibitor called ritonavir and one of two NRTIs -- either d4T or didanosine. The ... -Forbes

Stavudine, didanosine and AZT pose diabetes risk in D:A:D study  -  Nov 20, 2006
Aidsmap,The other two nucleosides associated with diabetes were ddI (didanosine, Videx) and AZT (zidovudine, used most frequently in Combivir) though they carried

South Africa: Scientists Warn State-Supplied Aids Drug Poses ...  -  Dec 6, 2006
AllAfrica.com,If patients develop severe side-effects or resistance, they switch to "second-line therapy", based on zidovudine (AZT), didanosine (ddI),

Breakthrough deal signed for paediatric HIV drugs  -  Dec 1, 2006
Pharma Times (subscription),The other ARVs for which the Clinton Foundation has negotiated price reductions include abacavir, didanosine, efavirenz and zidovudine.

President Clinton Announces Breakthroughs In HIV/AIDS Treatment ...  -  Nov 30, 2006
Medical News Today (press release),In addition to the three ARVs included in the pediatric FDC, the other ARVs for which CHAI has negotiated price reductions include abacavir, didanosine,

FDA Accepts as ``Complete Response'' Oscient Pharmaceuticals ...  -  Nov 28, 2006
PipelineReview.com (press release),...interactions include probenicid, sucralfate, antacids containing aluminum or magnesium, iron, multivitamins containing metal cations, and didanosine.

Tenofovir kidney toxicity: real, but uncommon and usually reversible  -  Nov 21, 2006
Aidsmap,Renal safety profile of tenofovir plus didanosine containing regimens. Results from the DIDITEN cohort. Eighth Congress on Drug Therapy in HIV Infection,

Van klinische proef van Gilead op 16de internationale AIDS ...  Aug 14, 2006
Coadministration of ATRIPLA and didanosine should be undertaken with caution. Patients receiving this combination should be monitored ... -Netherlands Corporate News (persbericht)

Micronutrient supplement increases CD4 cell counts in patients on ...  Aug 24, 2006
All of the participants were taking antiretroviral therapy containing d4T (stavudine, Zerit) or ddI (didanosine, Videx / VidexEC), and had symptoms of ... -Aidsmap

Barr Reports GAAP Earnings of $3.12 Per Share for Fiscal 2006 and ...  Aug 15, 2006
..."Increased generic sales were driven by Desmopressin and Didanosine, and continued strength in our oral contraceptive portfolio. ... -Finanzen.net

Brain problems and peripheral neuropathy under-diagnosed in Asia ...  Aug 14, 2006
...so-called “d� drugs from the nucleoside analogue (NRTI) class of anti-HIV drugs, with 37% taking either d4T (stavudine, Zerit) or ddI (didanosine, Videx). ... -Aidsmap

IAC: Micronutrients Improve Immune Function In HIV  Aug 15, 2006
To be eligible for the study, patients also had to be taking either Videx (didanosine) or Zerit (stavudine) and have had persistent peripheral neuropathy. ... -MedPage Today

Drop d4T from first-line therapy, WHO advises low-income countries ...  Aug 8, 2006
It should be combined with didanosine (ddI) and another nucleoside not used in first-line treatment, such as tenofovir or abacavir. ... -Aidsmap

Roche to Discontinue Hivid  Jul 28, 2006
...and specific recommendations within treatment guidelines state that Hivid should not be administered with the HIV medications didanosine, lamivudine, stavudine ... -Facts and Comparisons

Primary Mania Versus HIV-Related Secondary Mania in Uganda  Jul 28, 2006
Br J Psychiatry 1988; 152:839–842[Abstract]. Brouillette MJ, Chouinard G, Lalonde R: Didanosine-induced mania in HIV infection (letter). ... -Am J Psychiatry (subscription)

Aurobindo receives US FDA approval for Didanosine (chewable) ...  Jul 12, 2006
Aurobindo Pharma is proud to announce that the US FDA has granted tentative approval for Didanosine Tablets (Chewable)of strengths 100mg, 150mg & 200mg. ... -Moneycontrol.com

Aurobindo gets USFDA approval for Didanosine tablets  Jul 12, 2006
Aurobindo Pharma (Q, N,C,F)* has received USFDA approval for Didanosine Tablets (Chewable) of strengths 100mg, 150mg & 200mg. This ... -Myiris.com

Aurobindo Gets USFDA Approval for Didanosine Chewable Tablets  Jul 12, 2006
Aurobindo Pharma Ltd today said it has received tentative approval by USFDA for its anti-HIV drug, Didanosine chewable tablets of 100mg, 150mg and 200mg ... -MedIndia

FDA Approves ATRIPLA(TM), the First Once-Daily Single Tablet ...  Jul 20, 2006
Coadministration of ATRIPLA and didanosine should be undertaken with caution. Patients receiving this combination should be monitored ... -dBusinessNews Newark

USFDA approval for Aurobindo's anti-HIV drug  Jul 12, 2006
Aurobindo Pharma Ltd has received USFDA's tentaive approval for its anti-HIV drug, Didanosine chewable tablets of 100mg, 150mg and 200mg strengths. ... -Andhra Cafe

Aurobindo Pharma Receives Tentative FDA Approval To Produce ...  Jul 13, 2006
...has granted tentative approval to Indian drug manufacturer Aurobindo Pharma to produce a chewable tablet form of the antiretroviral drug didanosine, Iris.com ... -Kaiser network.org

Fatty liver prevalence high with HIV/HCV coinfection: 'use ddI and ...  Jun 30, 2006
Individuals coinfected with HIV and hepatitis C virus (HCV) should use ddI (didanosine, Videx/Videx EC) and d4T (stavudine, Zerit) with caution, according to ... -Aidsmap

Aurobindo receives US FDA approval for Stavudine capsules  Jun 30, 2006
Stavudine is an antiviral agent of the nucleoside analog class, which includes zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC). The international. ... -Moneycontrol.com

15th HIV Resistance Workshop: does low-level resistance matter?  Jul 6, 2006
Previous studies have alluded to the evolution of K65R mutation associated with tenofovir (TDF) with prior ABC or didanosine (ddI) use and emergence of the L74V ... -Aidsmap

Oscient Pharmaceuticals Announces Meeting Date for FDA Advisory ...  Jun 28, 2006
Drug-drug interactions include probenicid, sucralfate, antacids containing aluminum or magnesium, iron, multivitamins containing metal cations, and didanosine. ... -Business Wire



Bristol-Myers Squibb and Gilead Sciences Submit New Drug ...  Apr 27, 2006
Drug interactions have been observed when didanosine, atazanavir, or lopinavir/ritonavir are co-administered with Viread, a component of Truvada, and dose ... - International News Service

Long-term study plays down risk of brain problems in HIV-positive ...  Apr 26, 2006
Treatment mainly consisted of monotherapy with AZT (zidovudine, Retrovir), ddI (didanosine, Videx) or ddC (zalcitabine, Hivid) although twelve patients had ... - Aidsmap





Next generation NRTI, DFC (formerly Reverset) discontinued to due ...  11 Apr 2006
Study 203 had found that a combination of DFC with ddI (didanosine, Videx/Videx EC led to a 50% incidence rate of grade 4 hyperlipasaemia, with seven of the 14 ... - Aidsmap

Oscient Pharmaceuticals' FACTIVE Tablets Subject of Poster ...  Apr 4, 2006
Drug-drug interactions include probenicid, sucralfate, antacids containing aluminum or magnesium, iron, multivitamins containing metal cations, and didanosine. ... - International News Service

Tenofovir DF Remains Safe After 4 Years in the Treatment of HIV ...  Apr 5, 2006
...toxicity observed in the placebo-controlled trials -- which was proposed as a major advantage over several older NRTIs, such as didanosine and stavudine ... - DG News

HIV/AIDS: Designer Medicines To The Rescue  Apr 4, 2006
...conducted several clinical trials in partnership with industry to test four other nucleoside RT inhibitors: zalcitabine (ddC), didanosine (ddI), stavudine (D4T ... - Nigeria Daily Independent

Aurobindo Pharma granted licence by BMS  Mar 17, 2006
Ltd today said that Bristol Myers Squibb (BMS) Company has granted licence to the company to market its antiretrovirals (ARV) Stavudine and Didanosine in 49 ... - Hindu

Bristol-Myers grants ARV license for two drugs to Aurobindo Pharma  Mar 17, 2006
Aurobindo Pharma Ltd has been given the license to market Stavudine and Didanosine, two important anti retro virals by Bristol-Myers Squibb Company. ... - domain-B

Aurobindo gets mktg license by BMS for 2 ARV drugs  Mar 17, 2006
Aurobindo Pharma Ltd said on Friday announced that the Company has been given the license to market Stavudine & Didanosine, two important Antiretrovirals by ... - India Infoline.com

Rare resistance mutation, K65N, means that multiple NRTIs don't ...  Mar 26, 2006
Et al. A rare reverse transcriptase mutation, K65N, confers reduced susceptibility to tenofovir, lamivudine and didanosine. AIDS 20: 787 – 789, 2006. - Aidsmap

US FDA Grants Traditional Approval for Gilead's Once-Daily HIV ...  Mar 8, 2006
Drug interactions have been observed when didanosine, atazanavir, or lopinavir/ritonavir are co-administered with Viread, a component of Truvada, and dose ... - DG News

Aurobindo Pharma granted licence for ARV products  Mar 17, 2006
Ltd on Friday said that Bristol Myers Squibb Company has granted licence to the company to market its anti-retrovirals (ARV) Stavudine and Didanosine in 49 ... - Hindu Business Line

Aurobindo to sell BMS' anti-AIDS drugs  Mar 17, 2006
...(BMS) to market two anti-AIDS drugs in 49 countries, the Indian company said on Friday. The licences are for Stavudine and Didanosine, Aurobindo said. ... - Reuters India

Aurobindo to sell Bristol AIDS drugs  Mar 17, 2006
...anti-AIDS drugs in 49 countries. The licences are for Stavudine and Didanosine, Aurobindo said. The licence allows the company to ... - Business Standard

Fringe wins for pharma, but cos seek stronger dose  Feb 28, 2006
Budget. Some of these drugs are cisplatin, stavudine, danazol and didanosine. However, the industry sees these as minor concessions. ... - Economic Times,

Simplified treatment regimens show promise in HIV-infected ...  Feb 6, 2006
They treated the patients with a once-daily regimen of three anti-HIV drugs comprising ddI (didanosine, Videx / Videx EC), FTC (emtricitabine, Emtriva) and ... - Aidsmap,

Barr Reports Second Quarter Fiscal 2006 GAAP Earnings of $0.88 Per ...  Feb 7, 2006
...increase is primarily related to strong sales of the Company's Desmopressin product that was launched in July 2005 and sales of its Didanosine product that was ... - MSN Money

CROI: Tenofovir and kidney toxicity - low rates seen, but some ...  Feb 9, 2006
Abstract #778. Crane H Didanosine and lower baseline body weight are associated with declining renal function among patients receiving tenofovir. ... - Aidsmap,

CROI: AZT, 3TC and FTC achieve good concentrations in the female ...  Feb 17, 2006
The women were treated with antiretroviral regimens that included 3TC, AZT, abacavir (Ziagen), ddI (didanosine, Videx), d4T (stavudine, Zerit), efavirenz ... - Aidsmap,


This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional